How many drugs treat Nasal polyp?

Drug Landscape tracks 2 marketed treatments for Nasal polyp (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/nasal-polyp.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Nasal polyp — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nasal polyp (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Nasal polyp, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Rhinocort	Rhinocort	Marinomed Biotech AG		Matrix metalloproteinase-9, Probable G-protein coupled receptor 97, Glucocorticoid receptor
Beclometasone	Beclometasone	Imperial College London		Matrix metalloproteinase-9, Probable G-protein coupled receptor 97, Glucocorticoid receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Nasal polyp
Imperial College London · 1 drug in Nasal polyp
Marinomed Biotech AG · 1 drug in Nasal polyp

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Nasal polyp:

Cite this brief

Drug Landscape (2026). Nasal polyp — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/nasal-polyp. Accessed 2026-06-10.

Nasal polyp full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing